[HTML][HTML] Opioid therapy for chronic nonmalignant pain: a review of the critical issues

RK Portenoy - Journal of pain and symptom management, 1996 - Elsevier
The controversy surrounding the, long term use of opioid drugs in patients with
nonmalignant pain has intensified in recent years. This debate is driven by a new …

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial

JS Gimbel, P Richards, RK Portenoy - Neurology, 2003 - AAN Enterprises
Background and objective: Opioid treatment has played a limited role in the management of
diabetic neuropathy, in part because of concerns about the responsiveness of neuropathic …

Opioids in pain management

H McQuay - The Lancet, 1999 - thelancet.com
Opioids are our most powerful analgesics, but politics, prejudice, and our continuing
ignorance still impede optimum prescribing. Just over 100 years ago, opium poppies were …

[PDF][PDF] Management of chronic low back pain

N Bogduk - Medical journal of Australia, 2004 - mja.com.au
Management of chronic low back pain Page 1 MJA Vol 180 19 January 2004 79 CLINICAL
UPDATE The Medical Journal of Australia ISSN: 0025-729X 19 January 2004 180 2 79-83 …

How expectations influence pain

HL Fields - Pain, 2018 - journals.lww.com
The actions of individuals are guided by the motivation to satisfy drives that are homeostatic
(hunger, thirst, thermoregulatory, and tissue protection) or species-specific (mating, care of …

[HTML][HTML] Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379]

AC Van de Vusse, SGM Stomp-van den Berg… - BMC neurology, 2004 - Springer
Abstract Background Complex Regional Pain Syndrome type one (CRPS I) or formerly
Reflex Sympathetic Dystrophy (RSD) is a disabling syndrome, in which a painful limb is …

Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain

L Allan, H Hays, NH Jensen, BLP de Waroux, M Bolt… - Bmj, 2001 - bmj.com
Objectives: To compare patients' preference for transdermal fentanyl or sustained release
oral morphine, their level of pain control, and their quality of life after treatment. Design …

[PDF][PDF] Opioid guidelines in the management of chronic non-cancer pain

AM Trescot, MV Boswell, SL Atluri, HC Hansen… - Pain physician, 2006 - academia.edu
Background: Opioid abuse has increased at an alarming rate. However, available evidence
suggests a wide variance in the use of opioids, as documented by different medical …

[PDF][PDF] Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain

TR Deer, HS Smith, AW Burton, JE Pope, DM Doleys… - Pain physician, 2011 - dolor.org.co
Background: Chronic persistent pain as a result of terminal illness, either as a consequence
of the disease or the necessary treatment, is common in patients with cancer. For these …

Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation

SH Roth, RM Fleischmann, FX Burch… - Archives of Internal …, 2000 - jamanetwork.com
Background Although opioid analgesics have well-defined efficacy and safety in treatment of
chronic cancer pain, further research is needed to define their role in treatment of chronic …